Background and Purpose: Motor tests performed at stroke onset have been shown to predict the recovery of upper limb motor impairment. Less is known about upper limb recovery at the level of functional activity or of participation and how spatial neglect may influence the integration of the upper limb in the activities of daily living (ADL). Our objective was to investigate whether the initial severity of spatial neglect may predict upper limb use in ADL. Methods: Eighty-two patients with a right-hemispheric stroke (RHS) were prospectively included in the study. They were assessed twice in the acute/subacute and in the subacute/chronic phases (mean time interval of 45 days) after stroke. The Catherine Bergego Scale (CBS) was used to quantify the influence of spatial neglect on the ADL. Contralesional upper limb use in the ADL was evaluated with the Lucerne international classification of function, disability and health-based Multidisciplinary Observation Scale. Hand strength was measured using the Jamar, dexterity with the Nine Hole Peg test, and tactile perception using the stereognosis subtest of the Nottingham Sensory Assessment. Cognitive functions were assessed with the Montreal Cognitive Assessment. Results: Regression analyses revealed that spatial neglect is an independent and a significant predictor of upper limb outcome. A CBS score of ≤5 at the time of admission to neurorehabilitation care was highly predictive for good upper limb use in the ADL 45 days later. Conclusions: This study demonstrates that spatial neglect severity, as observed in the ADL, is a significant and an independent predictor of upper limb outcome. Neglect therapy is thus needed to further improve contralesional upper limb use in the ADL in RHS patients.

1.
World Health Organization: The Global Burden of Disease: 2004 Update. Geneva, World Health Organization, 2004.
2.
Veerbeek JM, Kwakkel G, van Wegen EE, Ket JC, Heymans MW: Early prediction of outcome of activities of daily living after stroke: a systematic review. Stroke 2011;42:1482-1488.
3.
Nakayama H, Jørgensen HS, Raaschou HO, Olsen TS: Recovery of upper extremity function in stroke patients: the Copenhagen Stroke Study. Arch Phys Med Rehabil 1994;75:394-398.
4.
Byblow WD, Stinear CM, Barber PA, Petoe MA, Ackerley SJ: Proportional recovery after stroke depends on corticomotor integrity. Ann Neurol 2015;78:848-859.
5.
Winters C, van Wegen EE, Daffertshofer A, Kwakkel G: Generalizability of the maximum proportional recovery rule to visuospatial neglect early poststroke. Neurorehabil Neural Repair 2017;31:334-342.
6.
World Health Organization: International Classification of Functioning, Disability and Health (ICF), 2001.
7.
Fugl-Meyer AR, Jääskö L, Leyman I, Olsson S, Steglind S: The post-stroke hemiplegic patient. 1. A method for evaluation of physical performance. Scand J Rehabil Med 1975;7:13-31.
8.
Nijland RH, van Wegen EE, Harmeling-van der Wel BC, Kwakkel G; EPOS Investigators: Presence of finger extension and shoulder abduction within 72 hours after stroke predicts functional recovery: early prediction of functional outcome after stroke: the EPOS cohort study. Stroke 2010;41:745-750.
9.
Stinear CM, Barber PA, Petoe M, Anwar S, Byblow WD: The PREP algorithm predicts potential for upper limb recovery after stroke. Brain 2012;135(pt 8):2527-2535.
10.
Erel H, Levy DA: Orienting of visual attention in aging. Neurosci Biobehav Rev 2016;69:357-380.
11.
Di Monaco M, Schintu S, Dotta M, Barba S, Tappero R, Gindri P: Severity of unilateral spatial neglect is an independent predictor of functional outcome after acute inpatient rehabilitation in individuals with right hemispheric stroke. Arch Phys Med Rehabil 2011;92:1250-1256.
12.
Gialanella B, Ferlucci C: Functional outcome after stroke in patients with aphasia and neglect: assessment by the motor and cognitive functional independence measure instrument. Cerebrovasc Dis 2010;30:440-447.
13.
Azouvi P: The ecological assessment of unilateral neglect. Ann Phys Rehabil Med 2016;pii:S1877-0657(16)00003-8.
14.
Ottiger B, Vanbellingen T, Gabriel C, Huberle E, Koenig-Bruhin M, Pflugshaupt T, et al: Validation of the new Lucerne ICF based Multidisciplinary Observation Scale (LIMOS) for stroke patients. PLoS One 2015;10:e0130925.
15.
Vanbellingen T, Ottiger B, Pflugshaupt T, Mehrholz J, Bohlhalter S, Nef T, et al: The responsiveness of the Lucerne ICF-based Multidisciplinary Observation Scale: a comparison with the functional independence measure and the Barthel index. Front Neurol 2016;7:152.
16.
Hankey GJ: Stroke. Lancet 2017;389:641-654.
17.
Chen HM, Chen CC, Hsueh IP, Huang SL, Hsieh CL: Test-retest reproducibility and smallest real difference of 5 hand function tests in patients with stroke. Neurorehabil Neural Repair 2009;23:435-440.
18.
Chiti G, Pantoni L: Use of Montreal Cognitive Assessment in patients with stroke. Stroke 2014;45:3135-3140.
19.
Lincoln NB, Jackson JM, Adams SA: Reliability and revision of the Nottingham sensory assessment for stroke patients. Physiotherapy 1998;84:358-365.
20.
Wagner JM, Lang CE, Sahrmann SA, et al: Sensorimotor impairments and reaching performance in subjects with poststroke hemiparesis during the first few months of recovery. Phys Ther 2007;87:751-765.
21.
Bagg S, Pombo AP, Hopman W: Effect of age on functional outcomes after stroke rehabilitation. Stroke 2002;33:179-185.
22.
Nijboer T, van de Port I, Schepers V, Post M, Visser-Meily A: Predicting functional outcome after stroke: the influence of neglect on basic activities in daily living. Front Hum Neurosci 2013;7:182.
23.
Nijboer TC, Kollen BJ, Kwakkel G: The impact of recovery of visuo-spatial neglect on motor recovery of the upper paretic limb after stroke. PLoS One 2014;9:e100584.
24.
Verdon V, Schwartz S, Lovblad KO, Hauert CA, Vuilleumier P: Neuroanatomy of hemispatial neglect and its functional components: a study using voxel-based lesion-symptom mapping. Brain 2010;133(pt 3):880-894.
25.
Bowen A, Lincoln NB: Cognitive rehabilitation for spatial neglect following stroke. Cochrane Database Syst Rev 2007;2:CD003586.
26.
Laplane D, Degos JD: Motor neglect. J Neurol Neurosurg Psychiatry 1983;46:152-158.
27.
Feng W, Wang J, Chhatbar PY, Doughty C, Landsittel D, Lioutas VA, et al: Corticospinal tract lesion load: an imaging biomarker for stroke motor outcomes. Ann Neurol 2015;78:860-870.
28.
Carmichael ST: Emergent properties of neural repair: elemental biology to therapeutic concepts. Ann Neurol 2016;79:895-906.
29.
Wu CY, Chuang IC, Ma HI, Lin KC, Chen CL: Validity and responsiveness of the revised Nottingham sensation assessment for outcome evaluation in stroke rehabilitation. Am J Occup Ther 2016;70:7002290040p1-8.
30.
Rollnik JD, Janosch U: Current trends in the length of stay in neurological early rehabilitation. Dtsch Arztebl Int 2010;107:286-292.
31.
Duncan PW, Goldstein LB, Matchar D, Divine GW, Feussner J: Measurement of motor recovery after stroke. Outcome assessment and sample size requirements. Stroke 1992;23:1084-1089.
32.
Vossel S, Weiss PH, Eschenbeck P, Fink GR: Anosognosia, neglect, extinction and lesion site predict impairment of daily living after right-hemispheric stroke. Cortex 2013;49:1782-1789.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.